,IL-6R

Elham Mehdizadeh Marzenaki1, Mojgan Bandehpour2,3, Adel Haghighi4

  • 1Department of Molecular Medicine, School of Advanced Technologies, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

概括

改造的干白素-6受体 (IL-6R) 片段被设计为减少与糖蛋白130 (gp130) 的结合. 这种工程蛋白显示出作为一种具有成本效益的治疗方法来治疗IL-6相关疾病的潜力.